[Prediction of hyaline membrane disease by studying pulmonary surfactant in amniotic fluid (author's transl)].
D000653:Amniotic Fluid / Q000032:analysis*; D005260:Female; D005865:Gestational Age; D006801:Humans; D006819:Hyaline Membrane Disease / Q000175:diagnosis*; D007231:Infant, Newborn; D008722:Methods; D010713:Phosphatidylcholines / Q000032:analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism; D011296:Prenatal Diagnosis; D011379:Prognosis; D011650:Pulmonary Alveoli / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000032:analysis*; D013109:Sphingomyelins / Q000032:analysis
D010713:Phosphatidylcholines; D011663:Pulmonary Surfactants; D013109:Sphingomyelins
Evaluation du risque de maladie des membranes hyalines par l'étude du surfactant d'origine pulmonaire dans le liquide amniotique